Novartis to Invest USD84 Million in New Radiopharma Plant in China
Novartis China Radiopharmaceutical Production Project Lays Foundation Stones
Novartis China held a groundbreaking ceremony for its radiopharmaceutical manufacturing project in Haiyan, Zhejiang Province, today to officially start construction of its project. This is Novartis’ first radioligand therapy production base in China, expanding the production and supply capacity of innovative radioligand therapies in China and the world, helping the clinical application and development of China’s medical industry, further fulfilling Novartis’ commitment to continue to cultivate the Chinese market, and bringing efficient and safe innovative therapies to more Chinese patients.